Last 819.55 INR
Change Today +9.75 / 1.20%
Volume 723.7K
GNP On Other Exchanges
Natl India
As of 6:05 AM 11/28/14 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

Glenmark House

B D S Marg

Chakala, Off Western Express Highway

Andheri (East)

Mumbai, 400099


Phone: 91 22 4018 9999

Fax: 91 22 4018 9990

Glenmark Pharmaceuticals Limited, together with its subsidiaries, develops, manufactures, and markets pharmaceutical products. The company’s products include Crofelemer, an anti diarrheal drug for symptomatic relief of non-infectious diarrhoea in patients with HIV/AIDS on anti retro viral therapy; GRC 17536 for neuropathic pain and respiratory disorders; and GRC 27864, an orally bioavailable inhibitor of mPGES-1 to treat chronic inflammatory conditions, which is in Phase I trial. Its products also comprise Vatelizumab (GBR 500) that is in Phase II study for multiple sclerosis; GBR 900, which is in is Phase I trial for the treatment of chronic pain targeting TrkA, the receptor of nerve growth factor; and GBR 830, an anti-OX40 monoclonal antibody for autoimmune disorders. In addition, the company is involved in the formulations business that focuses on therapeutic areas, such as dermatology, anti-infectives, respiratory, cardiac, diabetes, gynecology, CNS, and oncology. It has operations in India, Latin America, Europe, the United States, and internationally. Glenmark Pharmaceuticals Limited was founded in 1977 and is headquartered in Mumbai, India.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GNP:IN 819.55 INR +9.75

GNP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Impax Laboratories Inc $31.95 USD -0.37
Jubilant Life Sciences Ltd 134.05 INR 0.00
Lannett Co Inc $49.13 USD -0.38
Ranbaxy Laboratories Ltd 612.35 INR 0.00
Taro Pharmaceutical Industries Ltd $143.49 USD -0.85
View Industry Companies

Industry Analysis


Industry Average

Valuation GNP Industry Range
Price/Earnings 36.1x
Price/Sales 3.4x
Price/Book 7.0x
Price/Cash Flow 25.6x
TEV/Sales 2.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLENMARK PHARMACEUTICALS LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at